We assessed the effect of leptin on human monocytes. Monocytes were isolated from 16 healthy obese and 10 lean healthy participants. Insulin sensitivity was assessed by euglycemic hyperinsulinemic clamp. Obese participants were subdivided into 2 subgroups, insulin sensitive (IS) and insulin resistant (IR). Monocyte properties (attachment to laminin 1, migration through laminin 1, surface expression of CD36, oxidized low-density lipoprotein [oxLDL] phagocytosis) were assessed pre- and poststimulation in vitro with leptin. Experiments were repeated after incubation with rosiglitazone and a Na+/H+ exchanger-1 inhibitor (cariporide). We found a significant correlation between insulin resistance and monocyte attachment to laminin and oxLDL phagocytosis. Leptin increased the atherosclerosis-related properties of monocytes in all groups, apart from surface expression of CD36 in IS obese participants. Incubation with rosiglitazone or cariporide attenuated the observed effects. Leptin induces monocyte dysfunction which may be atherogenic. Correlation with insulin resistance suggests that atherosclerosis might be accelerated before the onset of diabetes.
Athyros VG, Kakafika AI, Karagiannis A., Mikhailidis DPDo we need to consider inflammatory markers when we treat atherosclerotic disease? Atherosclerosis. 2008;200(1):1-12.
2.
Victor VM, Rocha M., Sola E., Bañuls C., Garcia-Malpartida K., Hernández-Mijares A.Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des. 2009;15(26):2988-3002.
3.
Ishigaki Y. , Oka Y., Katagiri H.Circulating oxidized LDL: a bio-marker and a pathogenic factor. Curr Opin Lipidol. 2009;20(5): 363-369.
4.
Paraskevas KI , Liapis CD, Mikhailidis DPLeptin: a promising therapeutic target with pleiotropic action besides body weight regulation . Curr Drug Targets. 2006;7(6):761-771.
5.
Takahashi K. , Takeya M., Sakashita N.Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Med Electron Microsc. 2002;35(4):179-203.
6.
Poulakou MV, Paraskevas KI, Wilson MR, et al. Apolipoprotein J and leptin levels in patients with coronary heart disease. In Vivo. 2008;22(4):537-542.
7.
Wallace AM, McMahon AD, Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation . 2001;104(25):3052-3056.
8.
Yamagishi SI , Edelstein D., Du XL, Kaneda Y., Guzmán M., Brownlee M.Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. J Biol Chem. 2001;276(27):25096-25100.
9.
Park HY, Kwon HM, Lim HJ, et al. Potential role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med. 2001;33(2):95-102.
10.
Oda A., Taniguchi T., Yokoyama M.Leptin stimulates rat aortic smooth muscle cell proliferation and migration . Kobe J Med Sci.2001;47(3):141-150.
11.
Parhami F., Tintut Y., Ballard A., Fogelman AM, Demer LLLeptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res. 2001;88(11):954-960.
12.
Nakata M., Yada T., Soejima N., Maruyama I.Leptin promotes aggregation of human platelets via the long form of its receptor . Diabetes. 1999;48(2):426-429.
13.
Santos-Alvarez J., Goberna R., Sanchez-Margalet V.Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol. 1999;194(1):6-11.
14.
Konstantinidis D., Paletas K., Koliakos G., Kaloyianni M.Signaling components involved in leptin-induced amplification of the atherosclerosis-related properties of human monocytes . J Vasc Res. 2008;46(3):199-208.
15.
Dong F., Zhang X., Ren J.Leptin regulates cardiomyocyte contractile function through endothelin-1 receptor-NADPH oxidase pathway. Hypertension. 2006;47(2):222-229.
16.
Defronzo RA , Jordan DT, Reubin A.Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237(3):E214-E223.
17.
Seager Dancigera J., Lutzb M., Hamaa S., et al. Method for large scale isolation, culture and cryopreservation of human monocytes suitable for chemotaxis, cellular adhesion assays, macrophage and dendritic cell differentiation . J Immunol Methods. 2004; 288(1-2):123-134.
18.
Verdegaal M. , Zegveld S., Van Furth R.Heat shock protein 65 induces CD62e, CD106, and CD54 on cultured human endothelial cells and increases their adhesiveness for monocytes and granulocytes. J Immunol. 1996;157(1):369-376.
19.
Baumgarth M. , Beier N., Gericke R.(2-methyl-5-(methylsulfonyl) benzoyl)guanidine Na+/H+ antiporter inhibitors. J Med Chem . 1997;40(13):2017-2034.
20.
Itabe H.Oxidized low-density lipoproteins: what is understood and what remains to be clarified. Biol Pharm Bull. 2003;26(1):1-9.
21.
Stephan ZF, Yurachek EC. Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL. J Lipid Res. 1993;34(2):325-330.
22.
Pavlov TS, Levchenko V., Karpushev AV, Vandewalle A., Staruschenko A.Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel. Mol Pharmacol.2009;76(6):1333-1340.
23.
Konstantinou-Tegou A., Kaloyianni M., Bourikas D., Koliakos G.The effect of leptin on Na(+)-H(+) antiport (NHE 1) activity of obese and normal subjects erythrocytes. Mol Cell Endocrinol. 2001;183(1-2):11-18.
24.
Li G., Barrett EJ, Ko SH, Cao W., Liu Z.Insulin and insulin-like growth factor-I receptors differentially mediate insulin-stimulated adhesion molecule production by endothelial cells . Endocrinology.2009;150(8):3475-3482.
25.
Kostidou E. , Koliakos G., Alamdari DH, Paletas K., Tsapas A., Kaloyianni M.Enhanced laminin carbonylation by monocytes in diabetes mellitus. Clin Biochem. 2007;40(9-10):671-679.
26.
Athyros VG, Tziomalos K., Karagiannis A., Anagnostis P., Mikhailidis DPShould adipokines be considered in the choice of the treatment of obesity-related health problems? . Curr Drug Targets2010;11(1):122-135.
27.
Beltowski J.Leptin and atherosclerosis. Atherosclerosis. 2006; 189(1):47-60.
28.
Bountouris I., Paraskevas KI, Koutouzis M., et al. Serum leptin levels in patients undergoing carotid endarterectomy: a pilot study. Angiology.2009;60(6):698-704.
29.
Heida NM, Leifheit-Nestler M., Schroeter MR, et al. Leptin enhances the potency of circulating angiogenic cells via src kinase and integrin (alpha)vbeta5: implications for angiogenesis in human obesity. Arterioscler Thromb Vasc Biol.2010;30(2):200-206.
30.
Gil A., Maria Aguilera C., Gil-Campos M., Canete R.Altered signalling and gene expression associated with the immune system and the inflammatory response in obesity. Br J Nutr . 2007; 98(suppl 1):S121-S126.
31.
Rasouli N., Yao-Borengasser A., Varma V., et al. Association of scavenger receptors in adipose tissue with insulin resistance in nondiabetic humans. Arterioscler Thromb Vasc Biol.2009; 29(9):1328-1335.
32.
Ghanim H., Aljada A., Hofmeyer D., et al. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation. 2004;110(12):1564-1571.
